MODTX — Modus Therapeutics Holding AB Share News
0.000.00%
Last trade - 00:00- SEK27.44m
- SEK14.95m
Brief: Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Brief: Modus Therapeutics Resolves On Directed Share Issue Of 20 Million Shares
Sweden's Modus Therapeutics narrows Q2 net loss, extends financing
Brief: Modus Therapeutics Q2 Net Income SEK -4.645 Million
Sweden's Modus Therapeutics Q1 net loss widens
Brief: Modus Therapeutics Q1 Net Income SEK -3.282 Million
Modus Therapeutics To Receive SEK 9.5 Mln From Warrants
Sweden's Modus Therapeutics reports bigger Q4 loss
Brief: Modus Therapeutics Q4 Net Income SEK -5.32 Million
Brief: Modus Therapeutics Q3 Net Income SEK -4.342 Million
Brief: Modus Therapeutics Gets Regulatory Approval For Study In Italy
Brief: Modus Therapeutics Resolves On Compensation Issue
Brief: Modus Therapeutics Q2 Net Income SEK -6.066 Million
Brief: Modus Therapeutics Q1 Net Income SEK -2.815 Million
Brief: Modus Therapeutics Opens Second Study Site For Phase IIA CKD-Anemia Study
Brief: Modus Therapeutics Secures SEK 5 Mln Bridge Financing
Brief: Modus Therapeutics Proposes No Dividend
Brief: Modus Therapeutics Q4 Net Income SEK -4.713 Million
Brief: Modus Starts Phase II Study With Sevuparin For Treatment Of Chronic Kidney Disease With Anemia